Sintx Technologies (NASDAQ:SINT) Director Christopher Michael Lyons Acquires 7,534 Shares of Stock

Sintx Technologies, Inc. (NASDAQ:SINT) Director Christopher Michael Lyons bought 7,534 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was acquired at an average cost of $2.90 per share, with a total value of $21,848.60. Following the completion of the transaction, the director directly owned 8,292 shares of the company’s stock, valued at approximately $24,046.80. This represents a 993.93% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Christopher Michael Lyons also recently made the following trade(s):

• On Wednesday, February 25th, Christopher Michael Lyons purchased 758 shares of Sintx Technologies stock. The shares were acquired at an average price of $2.96 per share, for a total transaction of $2,243.68.

Sintx Technologies Trading Up 4.4%

SINT stock opened at $2.87 on Wednesday. The firm has a market cap of $10.56 million, a PE ratio of -0.51 and a beta of 0.67. Sintx Technologies, Inc. has a 1 year low of $1.71 and a 1 year high of $6.78. The company has a fifty day simple moving average of $3.26 and a 200 day simple moving average of $3.67.

Analysts Set New Price Targets

SINT has been the topic of a number of recent analyst reports. Ascendiant Capital Markets cut their price objective on Sintx Technologies from $25.00 to $16.00 and set a “buy” rating on the stock in a research note on Monday, December 8th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Sintx Technologies in a research report on Thursday, January 22nd. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $16.00.

Hedge Funds Weigh In On Sintx Technologies

Several large investors have recently bought and sold shares of the stock. Geode Capital Management LLC boosted its stake in shares of Sintx Technologies by 33.5% in the 2nd quarter. Geode Capital Management LLC now owns 15,339 shares of the company’s stock valued at $49,000 after purchasing an additional 3,848 shares in the last quarter. Veracity Capital LLC grew its stake in Sintx Technologies by 10.3% during the third quarter. Veracity Capital LLC now owns 79,928 shares of the company’s stock worth $327,000 after buying an additional 7,464 shares during the last quarter. Finally, Virtus Wealth Solutions LLC acquired a new stake in shares of Sintx Technologies during the third quarter worth approximately $388,000. 18.38% of the stock is currently owned by institutional investors and hedge funds.

Sintx Technologies Company Profile

Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.